PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
Lei Wang(Beijing Tian Tan Hospital), Haiquan Chen(Fudan University Shanghai Cancer Center)
Cited by 162
Related Papers
HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways
|Oncotarget|2015|105
MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer
|Oncotarget|2016|79
ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
|PLoS ONE|2013|61
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
|OncoTargets and Therapy|2014|45
Oxidized phospholipids are ligands for LRP6
|Bone Research|2018|43